🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInternationalHas anyone dealt with japan glp-1 access? Page 4

Has anyone dealt with japan glp-1 access?

Dr.PeteFamMed Fri, Oct 18, 2024 at 5:49 PM 35 replies 1,913 viewsPage 4 of 7
tommy_boulder
Member
234
1,123
Nov 2024
Boulder, CO
Oct 20, 2024 at 4:21 AM#16
chris_chi24 said:
The version of this that has an answer is narrower than the version being asked.

Can confirm. Same sequence, different timescale. Nothing to add that would improve it.

50 0paul_denver, TinaHashiRN, robert_kc and 47 others
Reply Quote Save Share Report
BenResearch_OR
Senior Member
2,456
11,234
Dec 2023
Oregon
Oct 20, 2024 at 7:09 AM#17
TirzTom said:
Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a…

This is exactly what I could not find anywhere else. I will report back once I have actually tried it.

Last edited: Oct 20, 2024 at 8:09 AM
49 24PharmD_Rodriguez, julia.endo, JessicaM_2024 and 46 others
Reply Quote Save Share Report
PharmHunterJen
Member
567
2,345
Jul 2024
Illinois
Oct 20, 2024 at 9:57 AM#18

Clinical perspective, offered as context rather than as advice. If two explanations both fit, the useful question is which one predicts something the other does not. That is answerable; arguing about which sounds more plausible is not.

48 23kevin_tulsa, Dr.PainCLE, mike_mealprep and 45 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
josh_phd_bmore
Member
389
1,678
Jul 2024
Baltimore, MD
Oct 20, 2024 at 12:45 PM#19
PharmHunterJen said:
If two explanations both fit, the useful question is which one predicts something the other does not.

This is my experience too, for whatever a second data point is worth. The detail I would add is minor and it is already implied above.

47 22KarenAZ_mom, zoe_NC, Dr.ObesityLA and 44 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Oct 20, 2024 at 3:33 PM#20

Moderator note: the sourcing question belongs in the vendor section and has been split out. Carry on.

25 0PurityPaulOR, MaxMetOK, MounjBrad and 22 others
Reply Quote Save Share Report

Similar Threads

EU EMA compounding guidance — 2026 regulatory update9 replies
UK NHS GLP-1 prescribing — NICE TA875 and access guide7 replies
Australian TGA scheduling changes — peptide access 20268 replies
Canadian GLP-1 coverage — provincial formulary comparison6 replies
Purchasing GLP-1 in Mexico — legality, quality, and safety concerns6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register